170 related articles for article (PubMed ID: 33401002)
1. p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier.
Yuan L; Mo SW; Xu ZY; Lv H; Xu JL; Guo KB; Hu C; Wang XF; Chen GP; Qin JJ; Cheng XD
Pharmacol Res; 2021 Mar; 165():105411. PubMed ID: 33401002
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients.
Hu K; Zheng QM; Wang YP; Zhao MM; Sun ZG
Eur J Cancer Prev; 2023 Mar; 32(2):119-125. PubMed ID: 36484275
[TBL] [Abstract][Full Text] [Related]
3. Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation.
Shi Y; Yuan L; Xu J; Xu H; Wang L; Huang L; Xu Z; Cheng X
J Oncol; 2022; 2022():6065516. PubMed ID: 35756080
[TBL] [Abstract][Full Text] [Related]
4. Huaier Extract Induces Apoptosis in Hepatoblastoma Cells
Xu DQ; Yuan XJ; Hirayama M; Toyoda H
In Vivo; 2020; 34(5):2381-2388. PubMed ID: 32871763
[TBL] [Abstract][Full Text] [Related]
5. Huaier Granule Combined with Tegafur Gimeracil Oteracil Potassium Promotes Stage IIb Gastric Cancer Prognosis and Induces Gastric Cancer Cell Apoptosis by Regulating Livin.
Qi J; Xie FJ; Liu S; Yao CY; Liu WH; Cai GQ; Liao GQ
Biomed Res Int; 2020; 2020():2403595. PubMed ID: 32724797
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effect of Huaier extract against neuroblastoma cells
Xu DQ; Yuan XJ; Toyoda H; Hirayama M
Int J Med Sci; 2021; 18(4):1015-1023. PubMed ID: 33456359
[TBL] [Abstract][Full Text] [Related]
7. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
8. Effect of Huaier on Melanoma Invasion, Metastasis, and Angiogenesis.
Su D; Jiang B; Yang Y; Miao Y; Fu Q; Zhang F
Biomed Res Int; 2020; 2020():8163839. PubMed ID: 32596377
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.
Tokunaga R; Imamura Y; Nakamura K; Ishimoto T; Nakagawa S; Miyake K; Nakaji Y; Tsuda Y; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Saeki H; Yoshida N; Oki E; Watanabe M; Oda Y; Bass AJ; Maehara Y; Baba H
Oncotarget; 2016 Apr; 7(15):19748-61. PubMed ID: 26933914
[TBL] [Abstract][Full Text] [Related]
11. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
12. Huaier n-butanol extract suppresses proliferation and metastasis of gastric cancer via c-Myc-Bmi1 axis.
Wang Y; Lv H; Xu Z; Sun J; Ni Y; Chen Z; Cheng X
Sci Rep; 2019 Jan; 9(1):447. PubMed ID: 30679589
[TBL] [Abstract][Full Text] [Related]
13. Trametes robiniophila Murr in the treatment of breast cancer.
Li C; Wang X; Chen T; Wang W; Yang Q
Biomed Pharmacother; 2020 Aug; 128():110254. PubMed ID: 32480220
[TBL] [Abstract][Full Text] [Related]
14. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer.
Reim D; Gertler R; Novotny A; Becker K; zum Büschenfelde CM; Ebert M; Dobritz M; Langer R; Hoefler H; Friess H; Schumacher C
Ann Surg Oncol; 2012 Jul; 19(7):2108-18. PubMed ID: 22130620
[TBL] [Abstract][Full Text] [Related]
16. Diallyl disulfide inhibits the metastasis of type Ⅱ esophageal‑gastric junction adenocarcinoma cells via NF-κB and PI3K/AKT signaling pathways in vitro.
Yin X; Feng C; Han L; Ma Y; Jiao Y; Wang J; Jia L; Jing F; Gao X; Zhang Y; Zhang J
Oncol Rep; 2018 Feb; 39(2):784-794. PubMed ID: 29207122
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblast-derived CXCL12 causes tumor progression in adenocarcinoma of the esophagogastric junction.
Sugihara H; Ishimoto T; Yasuda T; Izumi D; Eto K; Sawayama H; Miyake K; Kurashige J; Imamura Y; Hiyoshi Y; Iwatsuki M; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Takamori H; Baba H
Med Oncol; 2015 Jun; 32(6):618. PubMed ID: 25920609
[TBL] [Abstract][Full Text] [Related]
18. HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma.
Wang ZY; Xiao W; Jiang YZ; Dong W; Zhang XW; Zhang L
Thorac Cancer; 2021 Mar; 12(5):650-658. PubMed ID: 33471419
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junction.
Hu P; Pang Z; Shen H; Wang G; Sun H; Du J
Tumour Biol; 2015 Apr; 36(4):2965-71. PubMed ID: 25487619
[TBL] [Abstract][Full Text] [Related]
20. Differential pathologic variables and outcomes across the spectrum of adenocarcinoma of the esophagogastric junction.
Reynolds JV; Ravi N; Muldoon C; Larkin JO; Rowley S; O'Byrne K; Hollywood D; O'Toole D
World J Surg; 2010 Dec; 34(12):2821-9. PubMed ID: 20827475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
